natgillin/translations-raw huggingface dataset:
Almindelige bivirkninger (kan påvirke op til 1 ud af 10 patienter) kvalme/opkastning unormal vandladning træthed svimmelhed (også når man rejser sig fra liggende eller siddende stilling) blodprøver, der viser en forhøjet mængde af et enzym, der måler muskel- og hjertefunktionen (kreatinkinase) eller stigning i stoffer, som måler nyrefunktionen (carbamid, kreatinin). 
Common side effects ( may affect up to 1 in 10 people): nausea/vomiting abnormal urination fatigue dizziness (including when getting up from a lying or sitting position) blood tests may show raised levels of an enzyme that measures the muscle and heart function (creatine kinase) or raised levels of substances that measure kidney function (blood urea nitrogen, creatinine).
Derfor frarådes brug af Irbesartan Hydrochlorothiazide Zentiva. 
Therefore, the use of Irbesartan Hydrochlorothiazide Zentiva is not recommended.
Almindelige bivirkninger (kan påvirke op til 1 ud af 10 patienter ) kvalme/opkastning unormal vandladning træthed svimmelhed (også når man rejser sig fra liggende eller siddende stilling) blodprøver, der viser en forhøjet mængde af et enzym, der måler muskel- og hjertefunktionen (kreatinkinase) eller stigning i stoffer, som måler nyrefunktionen (carbamid, kreatinin). 
Common side effects (may affect more than 1 in 10 people): nausea/vomiting abnormal urination fatigue dizziness (including when getting up from a lying or sitting position) blood tests may show raised levels of an enzyme that measures the muscle and heart function (creatine kinase) or raised levels of substances that measure kidney function (blood urea nitrogen, creatinine).
Af hensyn til miljøet må du ikke smide medicinrester i afløbet , toilettet eller skraldespanden. 
Do not throw awy any medicines via wastewater or household waste.
Øvrige indholdsstoffer: lactosemonohydrat, mikrokrystallinsk cellulose, croscarmellosenatrium, hypromellose, silica, magnesiumstearat, titaniumdioxid (E 171), macrogol 3350, rød, gul og sort jernoxid, prægelatiniseret majsstivelse, carnaubavoks. 
The other ingredients are lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, hypromellose, silicon dioxide, magnesium stearate, titanium dioxide, macrogol 3350, red, yellow and black ferric oxides, pregelatinized starch, carnauba wax.
Sådan skal du tage Irbesartan Hydrochlorothiazide Zentiva 
How to take Irbesartan Hydrochlorothiazide Zentiva
Betingelser for markedsføringstilladelse 
MARKETING AUTHORISATION NUMBERS
Ikke almindelige bivirkninger (kan påvirke op til 1 ud af 100 patienter ) diarré lavt blodtryk besvimelse hjertebanken rødmen hævelse problemer med seksuel formåen blodprøver kan vise nedsat mængde af kalium og natrium i blodet. 
Uncommon side effects (may affect up to 1 in 100 people): diarrhoea low blood pressure fainting heart rate increased flushing swelling sexual dysfunction (problems with sexual performance) blood tests may show lowered levels of potassium and sodium in your blood.
Derfor frarådes kombination af lithium og Irbesartan Hydrochlorothiazide Zentiva (se pkt. 
Therefore, the combination of lithium and Irbesartan Hydrochlorothiazide Zentiva is not recommended (see section 4.4).
Se punkt 2 ”CoAprovel indeholder lactose” 
Please see section 2 “Irbesartan Hydrochlorothiazide Zentiva contains lactose”.
Anvendelse af Irbesartan Hydrochlorothiazide Zentiva i ammeperioden frarådes. 
The use of Irbesartan Hydrochlorothiazide Zentiva during breast feeding is not recommended.
Forholdet mellem den laveste og den maksimale effekt var henholdsvis 68% og 76% for Irbesartan Hydrochlorothiazide Zentiva 150 mg /12,5 mg og Irbesartan Hydrochlorothiazide Zentiva 300 mg /12,5 mg, når effekten blev målt med blodtryksmanchet ved kontrolbesøg. 
The trough to peak effects measured by cuff during office visits were 68% and 76% for Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg and Irbesartan Hydrochlorothiazide Zentiva 300 mg/12.5 mg, respectively.
hvis du får hyppig opkastning eller diarré hvis du lider af nyreproblemer eller er nyretransplanteret hvis du lider af hjerteproblemer hvis du lider af leverproblemer hvis du lider af sukkersyge hvis du lider af erytematøs lupus (også kaldet lupus eller systemisk lupus erythematosus) hvis du lider af primær aldosteronisme (tilstand med høj produktion af hormonet aldosteron, som gør, at der ophobes natriumsalt i kroppen, og blodtrykket derfor stiger) hvis du tager en af følgende lægemidler, der anvendes til at behandle forhøjet blodtryk: 
if you get excessive vomiting or diarrhoea if you suffer from kidney problems or have a kidney transplant if you suffer from heart problems if you suffer from liver problems if you suffer from diabetes if you suffer from lupus erythematosus (also known as lupus or SLE) if you suffer from primary aldosteronism (a condition related to high production of the hormone aldosterone, which causes sodium retention and, in turn, an increase in blood pressure).
Samtidig behandling med Irbesartan Hydrochlorothiazide Zentiva og aliskiren-holdige lægemidler er kontraindiceret til patienter med diabetes mellitus eller nedsat nyrefunktion (glomerulær filtrationshastighed (GFR) < 60 ml/min/1,73 m2 ) (se pkt. 
Severe hepatic impairment, biliary cirrhosis and cholestasis The concomitant use of Irbesartan Hydrochlorothiazide Zentiva with aliskiren-containing products is contraindicated in patients with diabetes mellitus or renal impairment (glomerular filtration rate (GFR) <60 ml/min/1.73 m²) (see sections 4.5 and 5.1).
Digitalisglykosider: Thiazidinduceret hypokaliæmi eller hypomagnesiæmi øger forekomsten af digitalisinducerede kardielle arytmier (se pkt. 
Corticosteroids, ACTH: electrolyte depletion, particularly hypokalaemia, may be increased; Digitalis glycosides: thiazide induced hypokalaemia or hypomagnaesemia favour the onset of digitalis-induced cardiac arrhythmias (see section 4.4);
 i et 6 måneders toksicitetsstudie med irbesartan 90 mg/kg/dag, hydrochlorthiazid 90 mg/kg/dag, og irbesartan/hydrochlorthiazid 10/10 mg/kg/dag blev der observeret misfarvning, sår og fokal nekrose af ventrikelslimhinden hos rotter. 
• stomach discoloration, ulcers and focal necrosis of gastric mucosa were observed in few rats in a 6 months toxicity study at irbesartan 90 mg/kg/day, hydrochlorothiazide 90 mg/kg/day, and irbesartan/hydrochlorothiazide 10/10 mg/kg/day.
Kontakt lægen, før du tager Irbesartan Hydrochlorothiazide Zentiva, hvis du oplever følgende: hvis du får hyppig opkastning eller diarré hvis du lider af nyreproblemer eller er nyretransplanteret hvis du lider af hjerteproblemer hvis du lider af leverproblemer hvis du lider af sukkersyge hvis du lider af erytematøs lupus (også kaldet lupus eller systemisk lupus erythematosus) hvis du lider af primær aldosteronisme (tilstand med høj produktion af hormonet aldosteron, som gør, at der ophobes natriumsalt i kroppen, og blodtrykket derfor stiger) hvis du tager en af følgende lægemidler, der anvendes til at behandle forhøjet blodtryk: 
Talk to your doctor before taking Irbesartan Hydrochlorothiazide Zentiva and if any of the following apply to you: if you get excessive vomiting or diarrhoea if you suffer from kidney problems or have a kidney transplant if you suffer from heart problems if you suffer from liver problems if you suffer from diabetes if you suffer from lupus erythematosus (also known as lupus or SLE) if you suffer from primary aldosteronism (a condition related to high production of the hormone aldosterone, which causes sodium retention and, in turn, an increase in blood pressure).
6.1 eller over for andre sulfonamidderivater (hydrochlorthiazid er et sulfonamidderivat) Graviditet i 2. eller 3. trimester (se pkt. 
Hypersensitivity to the active substances or to any of the excipients listed in section 6.1, or to other sulfonamide-derived substances (hydrochlorothiazide is a sulfonamide-derived substance) Second and third trimesters of pregnancy (see sections 4.4 and 4.6) Severe renal impairment (creatinine clearance <30 ml/min) Refractory hypokalaemia, hypercalcaemia
Et randomiseret, dobbeltblindt, aktivt kontrolleret, parallelt multicenterforsøg af 8 ugers varighed har evalueret effekten og sikkerheden af Irbesartan Hydrochlorothiazide Zentiva som inital behandling ved svær hypertension (defineret som SeDBT ≥ 110 mmHg). 
Efficacy and safety of Irbesartan Hydrochlorothiazide Zentiva as initial therapy for severe hypertension (defined as SeDBP ≥ 110 mmHg) was evaluated in a multicentre, randomized, doubleblind, active-controlled, 8-week, parallel-arm study.
Lactosemonohydrat Hypromellose Titaniumdioxid (E 171) Macrogol 3000 
Titanium dioxide Macrogol 3000
Croscarmellosenatrium Hypromellose Silica 
Lactose monohydrate Hypromellose
Hver tablet af Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg tabletter indeholder 300 mg irbesartan og 25 mg hydrochlorthiazid. 
Each film-coated tablet of Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg contains 300 mg irbesartan and 25 mg hydrochlorothiazide.
LÆGEMIDLETS NAVN Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg filmovertrukne tabletter. 
NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg film-coated tablets.
Dosisjustering er ikke nødvendig hos ældre patienter. 
No dosage adjustment is necessary inolder people.
Irbesartan Hydrochlorothiazide Zentiva 150 mg/12,5 mg tabletter leveres i blisterpakninger af 14, 28, 56 eller 98 tabletter. 
Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Dog skal denne faste dosis-kombination gives med forsigtighed til patienter med mild til moderat nedsat nyrefunktion (kreatininclearance ≥ 30 ml/min, men < 60 ml/min). 
However, in patients with mild to moderate renal impairment (creatinine clearance ≥ 30 ml/min but <60 ml/min) this fixed dose combination should be administered with caution.
Zentiva må ikke anvendes til patienter med alvorlig nyrefunktionsnedsættelse (kreatininclearance < 30 ml/min) (se pkt. 
Irbesartan Hydrochlorothiazide Zentiva should not be used in patients with severe renal impairment (creatinine clearance <30 ml/min) (see section 4.3).
Irbesartan Hydrochlorothiazide Zentiva skal tages gennem munden. 
Irbesartan Hydrochlorothiazide Zentiva is for oral use.
MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP LÆGEMIDLETS NAVN Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg tabletter irbesartan/hydrochlorthiazid NAVN PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN Zentiva k.s. 
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg tablets irbesartan/hydrochlorothiazide NAME OF THE MARKETING AUTHORISATION HOLDER Zentiva k.s.
Hver tablet af Irbesartan Hydrochlorothiazide Zentiva 150 mg/12,5 mg tabletter indeholder 150 mg irbesartan og 12,5 mg hydrochlorthiazid. 
Each tablet of Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg contains 150 mg irbesartan and 12.5 mg hydrochlorothiazide.
Irbesartan Hydrochlorothiazide Zentiva 300 mg/12,5 mg tabletter leveres i blisterpakninger á 14, 28, 56 eller 98 tabletter. 
Irbesartan Hydrochlorothiazide Zentiva 300 mg/12.5 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Hver filmovertrukken tablet indeholder 38,5 mg lactose (som lactosemonohydrat). 
Each film-coated tablet contains 38.5 mg of lactose (as lactose monohydrate).
Der er hverken observeret rebound-hypertension for irbesartan eller hydrochlorthiazid. 
Although not specifically studied with the Irbesartan Hydrochlorothiazide Zentiva, rebound hypertension has not been seen with either irbesartan or hydrochlorothiazide.
MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP LÆGEMIDLETS NAVN Irbesartan Hydrochlorothiazide Zentiva 150 mg/12,5 mg tabletter irbesartan/hydrochlorthiazid NAVN PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN Zentiva k.s. 
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg tablets irbesartan/hydrochlorothiazide NAME OF THE MARKETING AUTHORISATION HOLDER Zentiva k.s.
Dog skal denne faste dosis-kombination gives med forsigtighed til patienter med mildt til moderat nedsat nyrefunktion (kreatininclearance ≥ 30 ml/min, men < 60 ml/min). 
However, in patients with mild to moderate renal impairment (creatinine clearance ≥30 ml/min but <60 ml/min) this fixed dose combination should be administered with caution.
Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg filmovertrukne tabletter irbesartan/hydrochlorthiazid 
Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg film-coated tablets irbesartan/hydrochlorothiazide
MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP LÆGEMIDLETS NAVN Irbesartan Hydrochlorothiazide Zentiva 300 mg/12,5 mg tabletter irbesartan/hydrochlorthiazid NAVN PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN Zentiva k.s. 
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide Zentiva 300 mg/12.5 mg tablets irbesartan/hydrochlorothiazide NAME OF THE MARKETING AUTHORISATION HOLDER Zentiva k.s.
Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg filmovertrukne tabletter er lyserød, bikonvekse, ovalformede med et hjerte præget på den ene side og nummeret 2788 på den anden side. 
What Irbesartan Hydrochlorothiazide Zentiva looks like and contents of the pack Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg film-coated tablets are pink, biconvex, ovalshaped, with a heart debossed on one side and the number 2788 engraved on the other side.
Hyperkalæmi 
cardiac arrhythmias
Hver tablet af Irbesartan Hydrochlorothiazide Zentiva 300 mg/12,5 mg tabletter indeholder 300 mg irbesartan og 12,5 mg hydrochlorthiazid. 
Each tablet of Irbesartan Hydrochlorothiazide Zentiva 300 mg/12.5 mg contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide.
Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg filmovertrukne tabletter leveres i blisterpakninger af 14, 28, 30, 56, 84, 90 eller 98 filmovertrukne tabletter. 
Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets.
Det skal du vide, før du begynder at tage Irbesartan Hydrochlorothiazide Zentiva Sådan skal du tage Irbesartan Hydrochlorothiazide Zentiva Bivirkninger 
What Irbesartan Hydrochlorothiazide Zentiva is and what it is used for What you need to know before you take Irbesartan Hydrochlorothiazide Zentiva How to take Irbesartan Hydrochlorothiazide Zentiva Possible side effects
Dosisjustering er ikke nødvendig til patienter med nedsat nyrefunktion, hvis den renale kreatinin-clearance er  30 ml/min (se pkt. 
No dosage adjustment is necessary in patients with renal impairment whose creatinine clearance is ≥30 ml/min.
EU/1/06/377/001 - 14 tabletter EU/1/06/377/002 - 28 tabletter EU/1/06/377/003 - 56 tabletter EU/1/06/377/004 - 56 x 1 tabletter EU/1/06/377/005 - 98 tabletter 
EU/1/06/377/001 - 14 tablets EU/1/06/377/002 - 28 tablets EU/1/06/377/003 - 56 tablets EU/1/06/377/004 - 56 x 1 tablets EU/1/06/377/005 - 98 tablets
EU/1/06/377/006 - 14 tabletter EU/1/06/377/007 - 28 tabletter EU/1/06/377/008 - 56 tabletter EU/1/06/377/009 - 56 x 1 tabletter EU/1/06/377/010 - 98 tabletter 
EU/1/06/377/006 - 14 tablets EU/1/06/377/007 - 28 tablets EU/1/06/377/008 - 56 tablets EU/1/06/377/009 - 56 x 1 tablets EU/1/06/377/010 - 98 tablets
Irbesartan Hydrochlorothiazide Zentiva 150 mg/12,5 mg tabletter irbesartan/hydrochlorthiazid 
Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
LÆGEMIDLETS NAVN Irbesartan Hydrochlorothiazide Zentiva 150 mg/12,5 mg filmovertrukne tabletter. 
NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg film-coated tablets.
EU/1/06/377/017 - 14 tabletter EU/1/06/377/018 - 28 tabletter EU/1/06/377/031 - 30 tabletter EU/1/06/377/019 - 56 tabletter EU/1/06/377/020 - 56 x 1 tabletter EU/1/06/377/021 - 84 tabletter EU/1/06/377/032 - 90 tabletter EU/1/06/377/022 - 98 tabletter 
EU/1/06/377/017 - 14 tablets EU/1/06/377/018 - 28 tablets EU/1/06/377/031 - 30 tablets EU/1/06/377/019 - 56 tablets EU/1/06/377/020 - 56 x 1 tablets EU/1/06/377/021 - 84 tablets EU/1/06/377/032 - 90 tablets EU/1/06/377/022 - 98 tablets
Irbesartan Hydrochlorothiazide Zentiva 150 mg/12,5 mg filmovertrukne tabletter leveres i blisterpakninger af 14, 28, 30, 56, 84, 90 eller 98 filmovertrukne tabletter. 
Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets.
EU/1/06/377/011 - 14 tabletter EU/1/06/377/012 - 28 tabletter EU/1/06/377/029 - 30 tabletter EU/1/06/377/013 - 56 tabletter EU/1/06/377/014 - 56 x 1 tabletter EU/1/06/377/015 - 84 tabletter EU/1/06/377/030 - 90 tabletter EU/1/06/377/016 - 98 tabletter 
EU/1/06/377/011 - 14 tablets EU/1/06/377/012 - 28 tablets EU/1/06/377/029 - 30 tablets EU/1/06/377/013 - 56 tablets EU/1/06/377/014 - 56 x 1 tablets EU/1/06/377/015 - 84 tablets EU/1/06/377/030 - 90 tablets EU/1/06/377/016 - 98 tablets
Irbesartan Hydrochlorothiazide Zentiva 300 mg/12,5 mg tabletter irbesartan/hydrochlorthiazid 
Irbesartan Hydrochlorothiazide Zentiva 300 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
LÆGEMIDLETS NAVN Irbesartan Hydrochlorothiazide Zentiva 300 mg/12,5 mg filmovertrukne tabletter. 
NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide Zentiva 300 mg/12.5 mg film-coated tablets.
Indlægsseddel: Information til brugeren Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg filmovertrukne tabletter irbesartan/hydrochlorthiazid 
Package leaflet: Information for the patient Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg film-coated tablets irbesartan/hydrochlorothiazide
EU/1/06/377/023 - 14 tabletter EU/1/06/377/024 - 28 tabletter EU/1/06/377/033 - 30 tabletter EU/1/06/377/025 - 56 tabletter EU/1/06/377/026 - 56 x 1 tabletter EU/1/06/377/027 - 84 tabletter EU/1/06/377/034 - 90 tabletter EU/1/06/377/028 - 98 tabletter 
EU/1/06/377/023 - 14 tablets EU/1/06/377/024 - 28 tablets EU/1/06/377/033 - 30 tablets EU/1/06/377/025 - 56 tablets EU/1/06/377/026 - 56 x 1 tablets EU/1/06/377/027 - 84 tablets EU/1/06/377/034 - 90 tablets EU/1/06/377/028 - 98 tablets
Sverige Zentiva, k.s. 
Lietuva Zentiva, k.s.
Irbesartan Hydrochlorothiazide Zentiva 300 mg/12,5 mg filmovertrukne tabletter leveres i blisterpakninger af 14, 28, 30, 56, 84, 90 eller 98 filmovertrukne tabletter. 
Irbesartan Hydrochlorothiazide Zentiva 300 mg/12.5 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets.
Følgende ændringer, observeret hos rotter og makakaber, der fik en kombination af irbesartan/hydrochlorthiazid på 10/10 og 90/90 mg/kg/dag, blev også set ved anvendelse af de individuelle stoffer og/eller var sekundære til blodtryksnedsættelse (der blev ikke observeret signifikante toksikologiske interaktioner):  nyreforandringer karakteriseret ved let øgning af serum-urea og kreatinin samt hyperplasi/hypertrofi af det juxtaglomerulære apparat, hvilket er en direkte konsekvens af interaktion mellem irbesartan og renin angiotensin systemet; let fald i erytrocytparametre (erytrocytter, hæmoglobin, hæmatokrit); 
The following changes, observed in rats and macaques receiving the irbesartan/hydrochlorothiazide combination at 10/10 and 90/90 mg/kg/day, were also seen with one of the two medicinal products alone and/or were secondary to decreases in blood pressure (no significant toxicologic interactions were observed):
Forholdet mellem den laveste og den maksimale effekt af Irbesartan Hydrochlorothiazide Zentiva 150 mg /12,5 mg var 100%, når blodtrykket blev monitoreret ambulant. 
When measured by ambulatory blood pressure monitoring, the trough to peak effects of Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg were 100%.
Om nødvendigt kan Irbesartan Hydrochlorothiazide Zentiva kombineres med andre antihypertensiva (se pkt. 
When necessary, Irbesartan Hydrochlorothiazide Zentiva may be administered with another antihypertensive medicinal product (see sections 4.3, 4.4, 4.5 and 5.1).
Irbesartan Hydrochlorothiazide Zentiva 150 mg/12,5 mg filmovertrukne tabletter er ferskenfarvet, bikonvekse, ovalformede med et hjerte præget på den ene side og nummeret 2875 på den anden side. 
What Irbesartan Hydrochlorothiazide Zentiva looks like and contents of the pack Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg film-coated tablets are peach, biconvex, ovalshaped, with a heart debossed on one side and the number 2875 engraved on the other side.
Irbesartan Hydrochlorothiazide Zentiva 300 mg/12,5 mg filmovertrukne tabletter er ferskenfarvet, bikonvekse, ovalformede med et hjerte præget på den ene side og nummeret 2876 på den anden side. 
What Irbesartan Hydrochlorothiazide Zentiva looks like and contents of the pack Irbesartan Hydrochlorothiazide Zentiva 300 mg/12.5 mg film-coated tablets are peach, biconvex, ovalshaped, with a heart debossed on one side and the number 2876 engraved on the other side.
KVALITATIV OG KVANTITATIV SAMMENSÆTNING Hver filmovertrukken tablet indeholder 150 mg irbesartan og 12,5 mg hydrochlorthiazid. 
QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 150 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Irbesartan Hydrochlorothiazide Zentiva 150 mg/12,5 mg tabletter er ferskenfarvet, bikonvekse, ovalformede med et hjerte præget på den ene side og nummeret 2775 på den anden side. 
What Irbesartan Hydrochlorothiazide Zentiva looks like and contents of the pack Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2775 engraved on the other side.
Irbesartan Hydrochlorothiazide Zentiva 300 mg/12,5 mg tabletter er ferskenfarvet, bikonvekse, ovalformede med et hjerte præget på den ene side og nummeret 2776 på den anden side. 
What Irbesartan Hydrochlorothiazide Zentiva looks like and contents of the pack Irbesartan Hydrochlorothiazide Zentiva 300 mg/12.5 mg tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2776 engraved on the other side.
LÆGEMIDLETS NAVN Irbesartan Hydrochlorothiazide Zentiva 150 mg/12,5 mg tabletter 
NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg tablets.
Indlægsseddel: Information til brugeren Irbesartan Hydrochlorothiazide Zentiva 150 mg/12,5 mg tabletter irbesartan/hydrochlorthiazid 
Package leaflet: Information for the patient Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
Zentiva 150 mg/12,5 mg.  Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg kan gives til patienter, der er utilstrækkeligt regulerede med Irbesartan Hydrochlorothiazide Zentiva 300 mg /12,5 mg. 
• Irbesartan Hydrochlorothiazide Zentiva 300 mg/25 mg may be administered in patients insufficiently controlled by Irbesartan Hydrochlorothiazide Zentiva 300 mg/12.5 mg. Doses higher than 300 mg irbesartan/25 mg hydrochlorothiazide once daily are not recommended.
Indlægsseddel: Information til brugeren Irbesartan Hydrochlorothiazide Zentiva 300 mg/12,5 mg tabletter irbesartan/hydrochlorthiazid 
Package leaflet: Information for the patient Irbesartan Hydrochlorothiazide Zentiva 300 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
LÆGEMIDLETS NAVN Irbesartan Hydrochlorothiazide Zentiva 300 mg/12,5 mg tabletter 
NAME OF THE MEDICINAL PRODUCT Irbesartan Hydrochlorothiazide Zentiva 300 mg/12.5 mg tablets.
Indlægsseddel: Information til brugeren Irbesartan Hydrochlorothiazide Zentiva 150 mg/12,5 mg filmovertrukne tabletter irbesartan/hydrochlorthiazid 
Package leaflet: Information for the patient Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg film-coated tablets irbesartan/hydrochlorothiazide
Irbesartan Hydrochlorothiazide Zentiva 150 mg/12,5 mg filmovertrukne tabletter irbesartan/hydrochlorthiazid 
Irbesartan Hydrochlorothiazide Zentiva 150 mg/12.5 mg film-coated tablets irbesartan/hydrochlorothiazide
Advarsler og forsigtighedsregler Kontakt lægen, før du tager Irbesartan Hydrochlorothiazide Zentiva, hvis du oplever følgende: 
Talk to your doctor before taking Irbesartan Hydrochlorothiazide Zentiva and if any of the following apply to you: